These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3772909

  • 1. Oral contraceptives and lipoprotein metabolism.
    Tikkanen MJ, Nikkilä EA.
    J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Sep; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 6. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 7. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 8. Long-term profile of a new progestin.
    Lippman J.
    Int J Fertil; 1992 Dec; 37 Suppl 4():218-22. PubMed ID: 1362189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in lipoproteins with various sex steroids.
    Teran AZ, Greenblatt RB, Chaddha JS.
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral contraception: past, present, and future perspectives.
    Mishell DR.
    Int J Fertil; 1992 Mar; 37 Suppl 1():7-18. PubMed ID: 1347521
    [Abstract] [Full Text] [Related]

  • 19. Oral contraception: past, present, and future perspectives.
    Mishell DR.
    Int J Fertil; 1991 Mar; 36 Suppl 1():7-18. PubMed ID: 1678381
    [Abstract] [Full Text] [Related]

  • 20. The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.
    Lachnit-Fixson U.
    Gynecol Endocrinol; 1996 Jun; 10(3):207-18. PubMed ID: 8862497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.